Literature DB >> 666300

In vitro activity of rifampin alone and in combination with nafcillin and Vancomycin against pathogenic strains of Staphylococcus aureus.

C U Tuazon, M Y Lin, J N Sheagren.   

Abstract

Twenty strains of Staphylococcus aureus isolated from patients with endocarditis were examined in vitro for susceptibility to rifampin, nafcillin, and vancomycin and to combinations of rifampin with nafcillin or vancomycin. Minimum bactericidal concentrations of rifampin ranged from 0.0031 to 0.0125 mug/ml, of nafcillin ranged from 0.078 to 0.312 mug/ml, and of vancomycin ranged from 0.312 to 1.25 mug/ml. The combination of rifampin with nafcillin was synergistic for 12 strains; the combination of rifampin plus vancomycin was synergistic for 5 of the isolates.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 666300      PMCID: PMC352328          DOI: 10.1128/AAC.13.5.759

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Synergistic effects of oleandomycin and rifamycin SV in experimental staphylococcal septicaemia in rabbits.

Authors:  S Banic; Z Stropnik
Journal:  Infection       Date:  1974       Impact factor: 3.553

2.  Therapy of experimental staphylococcal infection with antibiotic combinations.

Authors:  M E Campos; S Rabinovich; I M Smith
Journal:  J Lab Clin Med       Date:  1974-02

3.  Antibiotic synergy in experimental infection with Pseudomonas. II. The effect of carbenicillin, cephalothin, or cephanone combined with tobramycin or gentamicin.

Authors:  V T Andriole
Journal:  J Infect Dis       Date:  1974-02       Impact factor: 5.226

4.  Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies.

Authors:  G L Mandell; T K Vest
Journal:  J Infect Dis       Date:  1972-05       Impact factor: 5.226

5.  Bacteriologic studies of rifampin, a new semisynthetic antibiotic.

Authors:  C M Kunin; D Brandt; H Wood
Journal:  J Infect Dis       Date:  1969-02       Impact factor: 5.226

6.  Combination antibiotic therapy in staphylococcal endocarditis. The use of methicillin sodium-gentamicin sulfate therapy.

Authors:  H W Murray; F M Wigley; J J Mann; R R Arthur
Journal:  Arch Intern Med       Date:  1976-04

7.  Antimicrobial therapy of experimental endocarditis caused by Staphylococcus aureus.

Authors:  M A Sande; M L Johnson
Journal:  J Infect Dis       Date:  1975-04       Impact factor: 5.226

8.  Enhancement of the effects of anti-staphylococcal antibiotics by aminoglycosides.

Authors:  C Watanakunakorm; C Glotzbecker
Journal:  Antimicrob Agents Chemother       Date:  1974-12       Impact factor: 5.191

9.  Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis.

Authors:  M A Sande; K B Courtney
Journal:  J Lab Clin Med       Date:  1976-07

10.  Treatment of experimental staphylococcal infection with rifampin.

Authors:  M C Lobo; G L Mandell
Journal:  Antimicrob Agents Chemother       Date:  1972-09       Impact factor: 5.191

View more
  29 in total

1.  Efficacy of high doses of levofloxacin in experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.

Authors:  O Murillo; A Doménech; A Garcia; F Tubau; C Cabellos; F Gudiol; J Ariza
Journal:  Antimicrob Agents Chemother       Date:  2006-10-02       Impact factor: 5.191

2.  In vitro interaction between rifampin and clindamycin against pathogenic coagulase-negative staphylococci.

Authors:  M Arditi; R Yogev
Journal:  Antimicrob Agents Chemother       Date:  1989-02       Impact factor: 5.191

3.  Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model.

Authors:  H H Houlihan; R C Mercier; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

4.  In vitro interactions between rifampin and ampicillin or chloramphenicol against Haemophilus influenzae.

Authors:  T Jadavji; C G Prober; R Cheung
Journal:  Antimicrob Agents Chemother       Date:  1984-07       Impact factor: 5.191

5.  Treatment of experimental staphylococcal infections: effect of rifampin alone and in combination on development of rifampin resistance.

Authors:  G L Mandell; D R Moorman
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

6.  The management of infection and colonization due to methicillin-resistant Staphylococcus aureus: A CIDS/CAMM position paper.

Authors:  Andrew E Simor; Mark Loeb
Journal:  Can J Infect Dis       Date:  2004-01

7.  Use of rifampin in persistent coagulase negative staphylococcal bacteremia in neonates.

Authors:  N Margreth van der Lugt; Sylke J Steggerda; Frans J Walther
Journal:  BMC Pediatr       Date:  2010-11-19       Impact factor: 2.125

8.  Eradication of colonization by methicillin-resistant Staphylococcus aureus by using oral minocycline-rifampin and topical mupirocin.

Authors:  R Darouiche; C Wright; R Hamill; M Koza; D Lewis; J Markowski
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

9.  Combination of minocycline and rifampicin against methicillin- and gentamicin-resistant Staphylococcus aureus.

Authors:  E Yourassowsky; M P van der Linden; M J Lismont; F Crokaert
Journal:  J Clin Pathol       Date:  1981-05       Impact factor: 3.411

Review 10.  Use of rifampin in nonstaphylococcal, nonmycobacterial disease.

Authors:  A B Morris; R B Brown; M Sands
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.